123rf.com/guniitaNeurodegenerative DisordersNLS and Kadimastem: Swiss-israeli merger...NLS Pharmaceutics secures US$2m equity funding and signs US$25m equity facility to support merger with Kadimastem (Israel) to combine expertise in aiming to become a leader in regenerative medicine in … more ➔
wikicommonsUnited KingdomUK Government invests millions into new...UK focuses on digital health research: £600m (US$764m) for new data platform according to the five recommendations of the Sudlow report. more ➔
TIRmed Pharma ABImmunmodulationSwedish TIRmed Pharma raises 4,3m€ again...TIRmed Pharma secures 4,3m€ to advance immunomodulatory treatment options for atopic dermatitis into clinical development. Stockholm-based TIRmed Pharma has closed this funding round, led by Sciety … more ➔
Menarini GroupPartnershipMenarini and ERBC collaborateFrench ERBC and Menarini Biotech from Italy forge a new strategic alliance to accelerate biopharmaceutical development. more ➔
Freepik.comSwitzerlandSwitzerland needs more efforts in biomed...In February 2025, the Federal Office of Public Health (FOPH) announced that the Masterplan in Biomedicine will be discontinued. This sends a troubling signal at a time of growing protectionism and potential … more ➔
BioSpringCDMOBioSpring announces €100+m investment in...BioSpring GmbH has broken found for one of the world’s largest production facilities for pharmaceutical nucleic acid-based therapeutics. The new high-tech plant will significantly expand the company’s … more ➔
Johnson & JohnsonAntiinflammationMorphosys’ antibody still shining...The case of the psoriasis antiinflammation antibody guselkumab is a story of deals and cooperation and selling and buying royalties to fuel other innovation paths. J&J is right in the middle of the game … more ➔
American Academy of Dermatology;doi.org/10.1016/j.jaad.2019.03.056FinancingMoonLake in US$500m debt deal with Hercu...Swiss MoonLake Immunotherapeutics AG has secured up to US$500m in non-dilutive financing from life sciences debt specialist Hercules Capital to finance the potential 2027 launch of sonelokimab in hidradenitis … more ➔
Audiovisual Librairy of the European CommissionEU CommissionEU bioeconomy strategy enters crucial ph...Europe’s decision on how to combine economic growth and decarbonisation in the future depends on the renewal of the EU bioeconomy strategy. The question is whether the EU will fall further behind globally … more ➔
market.usRegulatoryEMA set to simplify biosimilar approvalThe EMA has asked the industry to share their thoughts on its draft guidelines for developing and assessing biosimilars. The idea is to make it easier for patients in the EU to get access to biosimilars, … more ➔
123rf.com/guniita
wikicommons
TIRmed Pharma AB
Menarini Group
Freepik.com
BioSpring
Johnson & Johnson
American Academy of Dermatology;doi.org/10.1016/j.jaad.2019.03.056
Audiovisual Librairy of the European Commission
market.us